A novel group of aminoglycosides which share some structural features of currently available aminoglycosides with regard to the backbone, while also having significant structural differences, is disclosed. The similarity enables these aminoglycosides to be highly potent and effective antibiotics, while the significant differences enable these aminoglycosides to reduce or even block antibiotic resistance. The aminoglycosides of the present invention are suitable for inhibition of antrax lethal factor, hence are suitable for use as a cure for anthrax.

 
Web www.patentalert.com

< Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof

> Therapeutically useful triethyleneglycol cholesteryl oligonucleotides

> Development of a preventive vaccine for filovirus infection in primates

~ 00569